BIOMAT Database Logo BIOMAT Database Logo

Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1. 2022

Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Given the promising clinical value of allosteric modulators of G protein-coupled-receptors (GPCRs), mechanistic understanding of how these modulators alter GPCR function is of significance. Here, we report the crystallographic and cryo-electron microscopy structures of the cannabinoid receptor CB1 bound to the positive allosteric modulator (PAM) ZCZ011. These structures show that ZCZ011 binds to an extrahelical site in the transmembrane 2 (TM2)-TM3-TM4 surface. Through (un)biased molecular dynamics simulations and mutagenesis experiments, we show that TM2 rearrangement is critical for the propagation of allosteric signals. ZCZ011 exerts a PAM effect by promoting TM2 rearrangement in favor of receptor activation and increasing the population of receptors that adopt an active conformation. In contrast, ORG27569, a negative allosteric modulator (NAM) of CB1, also binds to the TM2-TM3-TM4 surface and exerts a NAM effect by impeding the TM2 rearrangement. Our findings fill a gap in the understanding of CB1 allosteric regulation and could guide the rational design of CB1 allosteric modulators.

UI MeSH Term Description Entries
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000495 Allosteric Site A site on an enzyme which upon binding of a modulator, causes the enzyme to undergo a conformational change that may alter its catalytic or binding properties. Allosteric Sites,Site, Allosteric,Sites, Allosteric
D043884 Receptor, Cannabinoid, CB1 A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release. Cannabinoid Receptor CB1,CB1 Receptor,Receptor CB1, Cannabinoid,Receptor, CB1
D056004 Molecular Dynamics Simulation A computer simulation developed to study the motion of molecules over a period of time. Molecular Dynamics Simulations,Molecular Dynamics,Dynamic, Molecular,Dynamics Simulation, Molecular,Dynamics Simulations, Molecular,Dynamics, Molecular,Molecular Dynamic,Simulation, Molecular Dynamics,Simulations, Molecular Dynamics
D020285 Cryoelectron Microscopy Electron microscopy involving rapid freezing of the samples. The imaging of frozen-hydrated molecules and organelles permits the best possible resolution closest to the living state, free of chemical fixatives or stains. Electron Cryomicroscopy,Cryo-electron Microscopy,Cryo electron Microscopy,Cryo-electron Microscopies,Cryoelectron Microscopies,Cryomicroscopies, Electron,Cryomicroscopy, Electron,Electron Cryomicroscopies,Microscopies, Cryo-electron,Microscopies, Cryoelectron,Microscopy, Cryo-electron,Microscopy, Cryoelectron

Related Publications

Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Allosteric modulation of the cannabinoid CB1 receptor.
November 2005, Molecular pharmacology,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor.
May 2017, Medicinal research reviews,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Molecular basis for ligand modulation of the cannabinoid CB1 receptor.
July 2022, British journal of pharmacology,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor.
August 2015, Molecular pharmacology,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation.
June 2019, Journal of medicinal chemistry,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
November 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Modulation of CB1 cannabinoid receptor by allosteric ligands: Pharmacology and therapeutic opportunities.
September 2017, Neuropharmacology,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated reward.
November 2022, Pharmacological research,
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
April 2021, Molecules (Basel, Switzerland),
Xin Yang, and Xuehui Wang, and Zheng Xu, and Chao Wu, and Yangli Zhou, and Yifei Wang, and Guifeng Lin, and Kan Li, and Ming Wu, and Anjie Xia, and Jingming Liu, and Lin Cheng, and Jun Zou, and Wei Yan, and Zhenhua Shao, and Shengyong Yang
Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor.
March 2019, Acta pharmacologica Sinica,
Copied contents to your clipboard!